We are live on ! Find out more
OPTR

OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR

Delisted

OPTR was delisted on the 23rd of October, 2013.

Back to rankings

104 hedge funds and large institutions have $526M invested in OPTIMER PHARMACEUTICALS, INC. COM STK in 2013 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 34 increasing their positions, 25 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 25

9% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 33

1% more funds holding

Funds holding: 103 → 104 (+1)

18% less capital invested

Capital invested by funds: $642M → $526M (-$116M)

74% less call options, than puts

Call options by funds: $1.84M | Put options by funds: $6.99M

Holders
104
Holders Change
+1
Holders Change %
+0.97%
% of All Funds
3.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
36
Increased
34
Reduced
25
Closed
33
Calls
$1.84M
Puts
$6.99M
Net Calls
-$5.14M
Net Calls Change
-$9.23M

Top Buyers

Rank Fund Capital Flow
1
WIC
Water Island Capital
New York
+$38.6M
2
AAA
Alpine Associates Advisors
New Jersey
+$29.3M
3
DKCM
Davidson Kempner Capital Management
New York
+$24.4M
4
JG
Jefferies Group
New York
+$21.2M
5
Morgan Stanley
Morgan Stanley
New York
+$19.4M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$44.7M
2
DM
Deerfield Management
New York
-$43.8M
3
GIM
Granahan Investment Management
Massachusetts
-$38.1M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$35.3M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$27.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
26
D.E. Shaw & Co
New York
$4.41M +$2.19M +164,926 +89%
VOYA Investment Management
27
VOYA Investment Management
Georgia
$4.22M -$223K -16,800 -5%
SI
28
Standard Investments
New York
$3.23M +$3.39M +256,160 New
Bank of New York Mellon
29
Bank of New York Mellon
New York
$3.16M +$120K +9,059 +4%
PP
30
Paloma Partners
Connecticut
$3.15M +$2.65M +200,000 +400%
Geode Capital Management
31
Geode Capital Management
Massachusetts
$2.82M +$276K +20,823 +10%
TCIM
32
TIAA CREF Investment Management
New York
$2.77M -$61.3K -4,625 -2%
Grantham, Mayo, Van Otterloo & Co (GMO)
33
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$2.61M +$2.74M +207,000 New
Millennium Management
34
Millennium Management
New York
$2.59M -$636K -47,974 -19%
MCM
35
Moore Capital Management
New York
$2.52M +$2.65M +200,000 New
Group One Trading
36
Group One Trading
Illinois
$2.48M +$1.09M +82,057 +71%
Allianz Asset Management
37
Allianz Asset Management
Germany
$2.06M -$835K -63,000 -28%
First Eagle Investment Management
38
First Eagle Investment Management
New York
$2.02M +$2.12M +160,100 New
SAM
39
Silverback Asset Management
North Carolina
$2M +$2.1M +158,684 New
BIM
40
BlackRock Investment Management
Delaware
$1.74M +$124K +9,344 +7%
NCCM
41
Nine Chapters Capital Management
New Jersey
$1.71M +$1.8M +135,700 New
BCMU
42
BlueCrest Capital Management (UK)
Guernsey
$1.64M +$1.73M +130,263 New
GF
43
Gabelli Funds
New York
$1.64M +$1.72M +130,000 New
Charles Schwab
44
Charles Schwab
California
$1.58M +$79.8K +6,020 +5%
PAMP
45
Polar Asset Management Partners
Ontario, Canada
$1.45M +$1.52M +114,846 New
Ameriprise
46
Ameriprise
Minnesota
$1.4M +$1.27M +96,203 +646%
Goldman Sachs
47
Goldman Sachs
New York
$1.32M +$944K +71,266 +214%
Norges Bank
48
Norges Bank
Norway
$1.21M – – –
AllianceBernstein
49
AllianceBernstein
Tennessee
$1.16M -$6.91M -521,394 -85%
Wellington Management Group
50
Wellington Management Group
Massachusetts
$1.15M -$44.7M -3,374,116 -97%
1
2
3 4 5

OPTR Hedge Fund Activity: Q3 2013 in Review

104 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) for Q3 2013, worth a combined $526M — down 18% from $642M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new OPTR positions and 33 closed out — a net gain of 3 holders — while 34 added to existing stakes and 25 trimmed.

The largest buyer was Water Island Capital, adding an estimated $38.6M. The largest seller was Wellington Management Group, cutting an estimated $44.7M.

  • 104 institutional investors held OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) as of Q3 2013, up from 103 in Q2 2013.
  • Funds reported $526M of OPTIMER PHARMACEUTICALS, INC. COM STK stock for Q3 2013, down 18% quarter-over-quarter.
  • 36 funds opened new OPTIMER PHARMACEUTICALS, INC. COM STK positions in Q3 2013 and 33 closed out, a net change of +3 holders.
  • The largest OPTIMER PHARMACEUTICALS, INC. COM STK buyer in Q3 2013 was Water Island Capital, an estimated $38.6M added.
  • The largest OPTIMER PHARMACEUTICALS, INC. COM STK seller in Q3 2013 was Wellington Management Group, an estimated $44.7M sold.

Based on aggregated 13F filings for Q3 2013.